<table id="i884f1f10-0f1e-43cb-81c3-367fc0547dd8" width="90%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 7 CLARITHROMYCIN SUSCEPTIBILITY TEST RESULTS AND 
CLINICAL/BACTERIOLOGIC OUTCOMES A FOR A THREE DRUG REGIMEN (RABEPRAZOLE 20 MG 
TWICE DAILY, AMOXICILLIN 1000 MG TWICE DAILY, AND CLARITHROMYCIN 500 MG TWICE 
DAILY FOR 7 OR 10 DAYS)</caption>
<col align="center" width="20%"></col>
<col align="center" width="20%"></col>
<col align="center" width="20%"></col>
<col align="center" width="20%"></col>
<col align="center" width="5%"></col>
<col align="center" width="5%"></col>
<col align="center" width="5%"></col>
<col align="center" width="5%"></col>
<thead>
<tr>
<th>Days of RAC Therapy</th>
<th>Clarithromycin Pretreatment 
Results</th>
<th>Total Number</th>
<th>
<content stylecode="italics">H. 
pylori</content> Negative (Eradicated)</th>
<th colspan="4">
<content stylecode="italics">H. 
pylori</content> Positive (Persistent)<br/>Post-Treatment Susceptibility 
Results</th>
</tr>
<tr>
<th>S<sup>b</sup>
</th>
<th>I<sup>b</sup>
</th>
<th>R<sup>b</sup>
</th>
<th>No MIC</th>
</tr>
</thead>
<tbody>
<tr>
<td>7</td>
<td>Susceptible <sup>b</sup>
</td>
<td>129</td>
<td>103</td>
<td>2</td>
<td>0</td>
<td>1</td>
<td>23</td>
</tr>
<tr>
<td>7</td>
<td>Intermediate <sup>b</sup>
</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>7</td>
<td>Resistant <sup>b</sup>
</td>
<td>16</td>
<td>5</td>
<td>2</td>
<td>1</td>
<td>4</td>
<td>4</td>
</tr>
<tr>
<td>10</td>
<td>Susceptible <sup>b</sup>
</td>
<td>133</td>
<td>111</td>
<td>3</td>
<td>1</td>
<td>2</td>
<td>16</td>
</tr>
<tr>
<td>10</td>
<td>Intermediate <sup>b</sup>
</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>10</td>
<td>Resistant <sup>b</sup>
</td>
<td>9</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>5</td>
<td>3</td>
</tr>
</tbody>
</table>